If you use a Medtronic MiniMed insulin pump, or know someone who does, the last few years have brought a string of unsettling headlines: a major Class I recall, reports of dangerous dosing errors, patient injuries, and lawsuits that are now grinding through the court system. This guide cuts through the noise and gives you a clear, current picture of what happened, where the litigation stands in 2026, and what your options are if you were harmed.
At a Glance
| Topic | Key Facts |
|---|---|
| Affected devices | MiniMed 630G, 670G, and other 600 series pumps |
| Core defect | Retainer ring failure causing insulin over- or under-delivery |
| FDA classification | Class I recall (highest severity) |
| U.S. devices recalled | 322,005 units (2019–2020 retainer ring recall) |
| FDA complaints filed | 26,421 complaints; 2,175 injuries; 1 confirmed death |
| 2024 battery recall | Additional 24,595 units (630G/700G) |
| Litigation status | Individual lawsuits active; no MDL formed; preemption defense causing dismissals |
| Latest development | October 2025: Medtronic wins dismissal in investor suit |
What Is the Medtronic Insulin Pump Lawsuit About?
The Medtronic insulin pump lawsuit centers on a mechanical defect in the company's MiniMed 600 series pumps that could cause patients to receive too much or too little insulin. For someone managing type 1 or type 2 diabetes, a dosing error of this kind is not a minor inconvenience. It can trigger a medical emergency within hours.
The lawsuits allege that Medtronic knew about the defect, delayed its response, and failed to adequately warn patients and healthcare providers.
How the Retainer Ring Defect Works
The MiniMed 600 series pumps use a small plastic retainer ring to hold the insulin cartridge in place inside the device. When that ring cracks, breaks, or goes missing entirely, the cartridge can shift out of alignment. Once the cartridge is misaligned, the pump's drive mechanism may not push insulin correctly, leading to either a dangerous surge in insulin delivery or a complete interruption.
Either outcome is serious. Too much insulin causes hypoglycemia (dangerously low blood sugar), which can progress to seizures or loss of consciousness if untreated. Too little insulin leads to hyperglycemia (high blood sugar), which, when prolonged, can escalate to diabetic ketoacidosis (DKA), a life-threatening condition.
Injuries Reported by Patients
According to FDA records, Medtronic received 26,421 complaints tied to the retainer ring defect, with 2,175 documented injuries and 1 confirmed death. Reported injuries include severe hypoglycemia, hyperglycemia, diabetic ketoacidosis, diabetic coma, and in the most serious cases, death. These figures represent only reported cases; the actual number of affected patients is likely higher given known underreporting patterns in medical device complaints.
Full Recall Timeline: Every Medtronic MiniMed Recall from 2009 to 2024
Medtronic's recall history with insulin pumps is longer than most people realize. The 2019 retainer ring event was not an isolated incident.
2009–2017: Early Recall Pattern
Between 2009 and 2017, the FDA issued multiple recalls affecting Medtronic's earlier Paradigm pump line. These involved issues including blocked membranes that could prevent air venting, infusion set defects, and motor malfunctions that caused inaccurate dosing. While none of these recalls reached the scale of the 2019 event, they established a documented pattern of recurring mechanical failures across generations of MiniMed devices. Plaintiffs' attorneys have cited this history in arguing that the retainer ring defect was not an unforeseeable anomaly but part of a broader quality control problem.
2019–2020: The Class I Retainer Ring Recall
The primary recall event at the center of most lawsuits occurred between October 2019 and August 2020. Medtronic recalled 322,005 MiniMed 600 series pumps in the U.S. after the FDA classified the defect as a Class I recall.
A Class I recall is the FDA's most serious designation. It applies when the agency determines there is a reasonable probability that continued use of the device will cause serious adverse health consequences or death. Class II recalls, by comparison, are issued for devices unlikely to cause serious harm. The Class I classification matters significantly in legal proceedings because it demonstrates that federal regulators independently confirmed the defect as a credible threat to patient safety.
The models included in this recall were the MiniMed 630G (all lots with a manufacture date before October 2019) and the MiniMed 670G (all lots with a manufacture date before August 2019).
2022 and 2024: Cybersecurity Vulnerabilities and Battery Recall
Two subsequent issues have expanded the scope of potential claims against Medtronic, though they are often overlooked in coverage focused on the retainer ring recall.
The first involves cybersecurity. In 2019 and again in 2022, the FDA issued warnings that certain MiniMed models, specifically the Paradigm 508 and Paradigm series pumps, contained wireless communication vulnerabilities that could theoretically allow an unauthorized person to interfere with insulin delivery remotely. Medtronic and the FDA advised patients using those models to transition to newer, more secure devices. This vulnerability drew attention from security researchers and raised questions about device oversight that have not been fully resolved.
The second is a more recent recall. In October 2024, Medtronic recalled an additional 24,595 MiniMed 630G and 700G pumps due to a battery-related defect. According to the FDA recall database, the battery issue created risk of unexpected device shutdown, which again poses the danger of interrupted insulin delivery. This October 2024 recall has opened a new eligibility pathway for patients who were not affected by the 2019 event but who have experienced harm from the battery issue.
Where the Lawsuits Stand in 2026, and Why Many Are Stalling
This is where most published guides fall short. The litigation picture in 2026 is more complicated than the "file now, collect later" framing found on many law firm websites.
Why There Is No Class Action MDL (Yet)
Many patients ask why there is no single consolidated class action or multidistrict litigation (MDL) proceeding for Medtronic insulin pump cases. The short answer is that the cases have not been centralized, and that is partly by design.
In an MDL, a panel of federal judges consolidates thousands of similar lawsuits into one proceeding before a single judge to manage pretrial discovery efficiently. MDL formation typically requires a large volume of federal cases raising common factual questions. While Medtronic insulin pump cases have been filed across multiple districts, the litigation has not yet reached the volume or coordination threshold that typically triggers MDL formation. Cases remain individual actions in their originating courts, which means each plaintiff must independently navigate pretrial motions, discovery, and the preemption challenge described below.
The Preemption Defense, Explained in Plain English
The biggest obstacle facing Medtronic insulin pump plaintiffs is a legal doctrine called federal preemption, and it has caused a significant number of cases to be dismissed outright.
Here is how it works. The FDA cleared Medtronic's MiniMed 600 series through a process called Premarket Approval, or PMA. PMA is the most stringent approval pathway for medical devices. Because PMA involves direct federal review and approval of the device's design and labeling, federal law provides manufacturers with a shield against state tort claims that would impose requirements "different from or in addition to" what the FDA has already required. This is the preemption defense.
In June 2023, a federal court in the Western District of Oklahoma dismissed two Medtronic insulin pump cases on precisely these grounds. The court found that the plaintiffs had not adequately alleged what is called a "parallel claim," meaning a claim that Medtronic violated its own FDA-approved requirements, rather than a broader state law negligence claim. A parallel claim is currently the only type of claim courts are allowing to proceed past the preemption hurdle. To survive a motion to dismiss, plaintiffs must allege specific ways in which Medtronic's conduct deviated from the FDA's own standards, not simply that the device was dangerous or defectively designed.
This does not mean all cases are lost. It does mean that claims framed only as general product liability without a specific parallel violation allegation face a high risk of dismissal.
Cases That Have Settled: Recent Examples
The preemption landscape makes some claims hard to pursue, but settlements are still happening for the right case profiles. A wrongful death case originating in Kentucky, involving a patient who passed away following a dosing error linked to the retainer ring defect, was settled in October 2024. The terms were not disclosed publicly. This outcome is meaningful because it demonstrates that Medtronic has chosen to resolve certain claims rather than take them to trial, particularly where the documented injury is severe and the evidentiary record is strong. Compensation in a resolved case can cover medical costs, lost wages, ongoing care needs, and non-economic damages.
Do You Still Qualify to File? Eligibility Checklist for 2026
Which Pump Models Are Covered
The primary recall covers MiniMed 630G units manufactured before October 2019 and MiniMed 670G units manufactured before August 2019. The October 2024 battery recall creates a separate, newer eligibility pathway for patients using MiniMed 630G and 700G devices who experienced harm related to unexpected device shutdown.
If you are unsure whether your specific pump is affected, the model number and lot number are printed on the device label. Medtronic's customer service line and the FDA's device recall database can confirm whether a specific unit falls within the recall scope.
Injury Severity Threshold
Not every patient who owned a recalled pump has a viable legal claim. Courts have consistently required that plaintiffs demonstrate a documented dosing event directly attributable to the defect, resulting in injury that required medical intervention. Hospitalization records, emergency room documentation, and physician notes linking the medical event to pump malfunction are the foundation of a qualifying claim. Patients who experienced a recall notification but no adverse health event are unlikely to meet the injury threshold courts have applied.
Statute of Limitations: Why Timing Matters Right Now
This is perhaps the most time-sensitive issue for anyone still weighing whether to act. Product liability statutes of limitations in most U.S. states run between two and four years from the date of injury or the date the patient reasonably should have known their injury was related to the device.
The primary recall was announced in 2019 and 2020. For patients injured in connection with that recall, the statute of limitations window may already be closing or closed in many states, depending on the specific date of injury and the applicable state law. Patients injured in connection with the October 2024 battery recall are operating within a newer window. If you believe you have a qualifying claim, consulting a product liability attorney promptly is advisable, not because filing quickly guarantees a better outcome, but because waiting can foreclose the option entirely.
What Compensation Could You Receive?
Settlement and verdict amounts in medical device cases vary considerably based on the severity and permanence of the injury, the strength of the documentary record, and the specific claims surviving preemption review. No reliable average settlement figure for Medtronic insulin pump cases exists in the public record, and any dollar figure circulating on legal marketing websites should be treated with skepticism.
What courts and settlements have covered in comparable cases includes economic damages such as hospitalization costs, ongoing medical care, lost income, and future treatment needs, as well as non-economic damages for pain, suffering, and in wrongful death cases, loss of companionship. The Kentucky wrongful death settlement cited above is the most recent confirmed example of compensation being paid in this litigation, though the settlement amount was not made public.
A product liability attorney working on contingency can provide a realistic assessment of what a specific case profile might support, without any upfront cost to the patient.
Patient Safety: What to Do If You Still Use a Recalled Pump
Legal options aside, the immediate priority for anyone using a recalled MiniMed pump is confirming that their device is safe to use.
FDA-Recommended Steps for 600 Series Users
The FDA's guidance for patients with affected MiniMed 600 series pumps includes inspecting the retainer ring before each cartridge change, checking for cracks, breaks, or absence of the ring, and stopping use of the pump immediately if any damage is found. Patients who identify a damaged or missing retainer ring should contact their healthcare provider before resuming insulin delivery and obtain instructions for manual dosing using injections until a replacement pump is received.
Medtronic established a process for providing replacement devices to affected patients at no charge. Patients who have not yet contacted Medtronic about a replacement should do so. The company's customer support line can be reached at 1-800-646-4633. If you are managing diabetes and need guidance on insulin injection sites as a temporary backup while waiting for a replacement pump, that information is worth reviewing with your care team.
The Cybersecurity Concern: Should You Worry?
The FDA's cybersecurity warnings about MiniMed Paradigm 508 and Paradigm series pumps caused significant concern when they were issued, and the question of whether an insulin pump can be hacked remains one of the more common patient questions about this litigation.
The practical answer is that the wireless vulnerability identified in those older Paradigm models was theoretical in nature. It required physical proximity, specific equipment, and technical knowledge to exploit, and no confirmed real-world attack on a patient's pump was ever reported. Medtronic's recommended response was to transition patients to newer, more secure device models. Patients still using the older Paradigm series should raise this question with their endocrinologist and ask whether a device upgrade is appropriate. Patients using current MiniMed 600 series devices are not subject to the same wireless concern.
How to Find a Medtronic Insulin Pump Lawyer
Most product liability attorneys who handle medical device cases work on a contingency fee basis, meaning they collect a percentage of any settlement or verdict and charge nothing unless the case resolves in the client's favor. This arrangement makes it accessible for patients to pursue claims regardless of their financial situation.
When consulting an attorney, bring documentation of your pump model and lot number, any correspondence from Medtronic about the recall, your medical records from any adverse events, and records of related hospitalizations or treatments. Questions worth asking include whether the attorney has experience with preemption defenses in PMA device cases, how they plan to frame the parallel violation claim, and what their honest assessment of viability is given the 2023 dismissal decisions.
Realistic timelines for medical device litigation are measured in years, not months. Cases that survive preemption challenges will still require discovery, expert witnesses, and often several rounds of motion practice before reaching resolution. Patients who are still experiencing the physical and financial effects of a pump-related injury may also benefit from exploring telehealth options to manage ongoing care while litigation proceeds. A virtual primary care provider can help coordinate diabetes management remotely, which may be especially useful for patients managing follow-up care alongside a legal process.
If you are in the early stages of understanding your options as a diabetes patient more broadly, Momentary Lab's AI healthcare navigator can help you orient to your condition and care choices before connecting with a specialist.
Frequently Asked Questions
Is there a recall on Medtronic insulin pumps?
Yes. Medtronic has issued multiple recalls affecting its MiniMed insulin pump line. The most significant was a Class I recall in 2019–2020 covering 322,005 MiniMed 630G and 670G devices in the U.S. due to a retainer ring defect that could cause dangerous dosing errors. A separate recall in October 2024 covered an additional 24,595 MiniMed 630G and 700G pumps for a battery-related issue. Patients can verify whether their specific device is affected by checking the FDA's recall database or contacting Medtronic directly.
What is the Medtronic MiniMed lawsuit about?
The lawsuits allege that Medtronic's MiniMed 600 series insulin pumps contained a defective retainer ring that could break or detach, causing the insulin cartridge to misalign and deliver incorrect doses. Plaintiffs claim Medtronic was aware of the defect and failed to act promptly or warn patients adequately. Injuries reported include severe hypoglycemia, hyperglycemia, diabetic ketoacidosis, diabetic coma, and in one confirmed case, death.
How do I know if my Medtronic pump is recalled?
Check the model number and lot number on your pump's label. The primary recall covers MiniMed 630G units made before October 2019 and MiniMed 670G units made before August 2019. The 2024 battery recall covers select MiniMed 630G and 700G units. The FDA's device recall database lists affected lot numbers, and Medtronic's customer service line (1-800-646-4633) can confirm whether a specific unit qualifies.
Can I file a lawsuit for a recalled Medtronic insulin pump?
You may be able to file a lawsuit if you own or owned one of the recalled models and suffered a documented injury requiring medical treatment as a result of a pump malfunction. However, Medtronic's PMA approval status gives it a significant legal defense under federal preemption doctrine, and courts have dismissed claims that did not allege a specific parallel violation of FDA requirements. The statute of limitations in your state will also affect eligibility, with some claims from the 2019–2020 recall potentially time-barred. A product liability attorney can evaluate your specific situation.
What is the Medtronic insulin pump lawsuit settlement payout?
No publicly verified average settlement amount exists for this litigation. The most recent confirmed settlement involved a wrongful death case in Kentucky that resolved in October 2024 for an undisclosed amount. Settlement values in medical device cases depend on injury severity, the strength of medical documentation, and the specific claims that survive preemption review. Published settlement "averages" on legal marketing websites are not based on verified case data and should not be relied upon.
What happened with the Medtronic investor lawsuit?
In October 2025, a federal court dismissed a separate investor suit against Medtronic related to its insulin pump disclosures. That case was filed by shareholders who alleged the company misled investors about the scope of the pump defect problem. Its dismissal does not affect individual patient injury claims but reflects the broader legal headwinds Medtronic has faced, and largely overcome, in litigation tied to the MiniMed recalls.
Finding the Right Support
Navigating a recalled medical device, a potential legal claim, and ongoing diabetes management at the same time is a significant burden. A doctor experienced in diabetes care can help you assess whether your current device is safe and what your management options are while you sort out next steps. For patients managing related cardiovascular risk factors that accompany long-term diabetes, understanding the macrovascular complications of diabetes may also be a useful conversation to have with your provider.
The legal landscape around these cases is genuinely complex, and the honest answer is that not every claim will succeed. But for patients who experienced a serious documented injury, the possibility of compensation remains real, and the right attorney can tell you quickly whether your situation fits the profile courts have been receptive to.
